Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,274
Closed -$204K 86
2025
Q1
$204K Sell
2,274
-1,166
-34% -$109K 0.1% 82
2024
Q4
$342K Sell
3,440
-225
-6% -$23.2K 0.17% 61
2024
Q3
$416K Buy
3,665
+60
+2% +$7.13K 0.2% 58
2024
Q2
$446K Hold
3,605
0.22% 56
2024
Q1
$475K Sell
3,605
-41
-1% -$5.05K 0.26% 53
2023
Q4
$397K Buy
+3,646
New +$378K 0.24% 55

Other funds holding MRK

PFC Capital Group's MRK Position: Q2 2025 in Review

PFC Capital Group sold out of Merck (MRK) in Q2 2025, closing a stake of 2,274 shares — an estimated $204K sold.

PFC Capital Group first reported a position in MRK in Q4 2023 and held it in 6 quarters. The position peaked at $475K in Q1 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • PFC Capital Group reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • PFC Capital Group sold 2,274 Merck shares in Q2 2025, an estimated $204K.
  • PFC Capital Group first reported a position in Merck in Q4 2023 and held it in 6 quarters.
  • PFC Capital Group's Merck position peaked at $475K in Q1 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on PFC Capital Group's 13F filing for Q2 2025, filed 12 Aug 2025.